BTR Capital Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.3M | Sell |
202,006
-1,725
| -0.8% | -$110K | 1.92% | 19 |
|
|
2022
Q2 | $12.8M | Buy |
203,731
+1,990
| +1% | +$132K | 1.84% | 22 |
|
|
2022
Q1 | $14.2M | Sell |
201,741
-2,605
| -1% | -$176K | 1.74% | 23 |
|
|
2021
Q4 | $12.8M | Buy |
204,346
+1,877
| +0.9% | +$118K | 1.44% | 28 |
|
|
2021
Q3 | $12.5M | Buy |
202,469
+5,424
| +3% | +$327K | 1.55% | 26 |
|
|
2021
Q2 | $11.8M | Buy |
197,045
+1,391
| +0.7% | +$88.2K | 1.47% | 29 |
|
|
2021
Q1 | $11.9M | Buy |
195,654
+850
| +0.4% | +$46.9K | 1.73% | 25 |
|
|
2020
Q4 | $9.15M | Buy |
194,804
+2,090
| +1% | +$90.6K | 1.43% | 26 |
|
|
2020
Q3 | $7.16M | Buy |
192,714
+7,482
| +4% | +$284K | 1.27% | 26 |
|
|
2020
Q2 | $6.76M | Sell |
185,232
-3,050
| -2% | -$106K | 1.27% | 27 |
|
|
2020
Q1 | $5.76M | Buy |
188,282
+16,075
| +9% | +$713K | 1.27% | 28 |
|
|
2019
Q4 | $8.78M | Buy |
172,207
+16,698
| +11% | +$806K | 1.51% | 25 |
|
|
2019
Q3 | $7.33M | Buy |
155,509
+4,249
| +3% | +$203K | 1.38% | 28 |
|
|
2019
Q2 | $7.51M | Buy |
151,260
+285
| +0.2% | +$13.4K | 1.4% | 27 |
|
|
2019
Q1 | $6.43M | Sell |
150,975
-3,335
| -2% | -$147K | 1.24% | 31 |
|
|
2018
Q4 | $6.34M | Sell |
154,310
-20,325
| -12% | -$872K | 1.33% | 31 |
|
|
2018
Q3 | $8.16M | Buy |
174,635
+1,261
| +0.7% | +$57.6K | 1.42% | 30 |
|
|
2018
Q2 | $7.56M | Buy |
173,374
+5,665
| +3% | +$264K | 1.46% | 31 |
|
|
2018
Q1 | $7.7M | Sell |
167,709
-2,020
| -1% | -$98K | 1.54% | 32 |
|
|
2017
Q4 | $8.58M | Sell |
169,729
-683
| -0.4% | -$36K | 1.68% | 25 |
|
|
2017
Q3 | $8.85M | Sell |
170,412
-20,050
| -11% | -$976K | 1.81% | 21 |
|
|
2017
Q2 | $9.33M | Buy |
190,462
+3,667
| +2% | +$170K | 1.91% | 19 |
|
|
2017
Q1 | $8.79M | Sell |
186,795
-788
| -0.4% | -$37.6K | 1.84% | 21 |
|
|
2016
Q4 | $7.43M | Hold |
187,583
| – | – | 1.67% | 24 |
|
|
2016
Q3 | $7.43M | Sell |
187,583
-3,055
| -2% | -$115K | 1.67% | 24 |
|
|
2016
Q2 | $6.77M | Sell |
190,638
-6,054
| -3% | -$236K | 1.55% | 26 |
|
|
2016
Q1 | $7.7M | Sell |
196,692
-1,324
| -0.7% | -$49.5K | 1.79% | 18 |
|
|
2015
Q4 | $8.51M | Buy |
198,016
+3,680
| +2% | +$162K | 1.93% | 16 |
|
|
2015
Q3 | $8.17M | Buy |
194,336
+3,927
| +2% | +$183K | 1.95% | 13 |
|
|
2015
Q2 | $9.5M | Buy |
190,409
+26,922
| +16% | +$1.27M | 2.24% | 11 |
|
|
2015
Q1 | $7.37M | Sell |
163,487
-2,081
| -1% | -$93.5K | 1.79% | 20 |
|
|
2014
Q4 | $7.98M | Sell |
165,568
-4,656
| -3% | -$221K | 2.18% | 14 |
|
|
2014
Q3 | $8.15M | Buy |
170,224
+376
| +0.2% | +$18.3K | 2.25% | 10 |
|
|
2014
Q2 | $8.41M | Buy |
169,848
+10,494
| +7% | +$491K | 2.31% | 9 |
|
|
2014
Q1 | $7.5M | Sell |
159,354
-6,648
| -4% | -$306K | 2.19% | 13 |
|
|
2013
Q4 | $7.98M | Sell |
166,002
-449
| -0.3% | -$20.1K | 2.28% | 10 |
|
|
2013
Q3 | $6.96M | Sell |
166,451
-7,136
| -4% | -$307K | 2.19% | 10 |
|
|
2013
Q2 | $7.08M | Buy |
+173,587
| New | +$6.38M | 2.2% | 13 |
|
Other funds holding MET
BTR Capital Management's MET Position: Q3 2022 in Review
BTR Capital Management reduced its MetLife (MET) stake by 0.85% in Q3 2022, selling an estimated $110K and leaving 202,006 shares worth $12.3M. The position accounts for 1.92% of the portfolio, ranked #19.
BTR Capital Management first reported a position in MET in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.2M in Q1 2022. 1,194 funds tracked by Wall St. Rank hold MET as of Q3 2022.
- BTR Capital Management held 202,006 shares of MetLife worth $12.3M as of Q3 2022.
- BTR Capital Management sold 1,725 MetLife shares in Q3 2022, an estimated $110K.
- MetLife made up 1.92% of BTR Capital Management's portfolio in Q3 2022, its #19 holding.
- BTR Capital Management first reported a position in MetLife in Q2 2013 and has held it in 38 quarters since.
- BTR Capital Management's MetLife position peaked at $14.2M in Q1 2022.
- 1,194 funds tracked by Wall St. Rank held MetLife as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.